NASDAQ:NMRD

Nemaura Medical - NMRD Stock Forecast, Price & News

$0.74

+0.03 (+4.21%)

(As of 03/22/2023 01:55 PM ET)

Add

Compare

Today's Range: $0.70
▼
$0.74
50-Day Range: $0.71
▼
$2.86
52-Week Range: $0.70
▼
$4.58

Volume: 32,936 shs
Average Volume: 184,826 shs
Market Capitalization: $21.38 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.50

Institutional Ownership

Nemaura Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 812.9% Upside
$6.50 Price Target
Short Interest: Healthy
0.26% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.97
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.56) to ($0.49) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

104th out of 983 stocks

Surgical & Medical Instruments Industry

11th out of 100 stocks

3.5

Analyst's Opinion

Consensus Rating
Nemaura Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $6.50, Nemaura Medical has a forecasted upside of 812.9% from its current price of $0.71.
Amount of Analyst Coverage
Nemaura Medical has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.26% of the float of Nemaura Medical has been sold short.
Short Interest Ratio / Days to Cover
Nemaura Medical has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Nemaura Medical has recently decreased by 71.72%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Nemaura Medical does not currently pay a dividend.
Dividend Growth
Nemaura Medical does not have a long track record of dividend growth.

4.5

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Nemaura Medical has received a 69.97% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Continuous glucose monitoring systems", "Continuous substance abuse monitoring systems", and "Continuous alcohol monitoring systems" products. See details.
Environmental Sustainability
The Environmental Impact score for Nemaura Medical is -0.97.

2.8

News and Social Media Coverage

News Sentiment
Nemaura Medical has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Nemaura Medical this week, compared to 0 articles on an average week.
Search Interest
Only 10 people have searched for NMRD on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
MarketBeat Follows
Only 6 people have added Nemaura Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nemaura Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
49.80% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 3.41% of the stock of Nemaura Medical is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Nemaura Medical are expected to grow in the coming year, from ($0.56) to ($0.49) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Nemaura Medical is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nemaura Medical is -1.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Nemaura Medical has a P/B Ratio of 35.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Nemaura Medical (NASDAQ:NMRD) Stock

Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.

Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

March 21, 2023 | finance.yahoo.com

Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton

March 15, 2023 | finance.yahoo.com

Nemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License Agreement

March 22, 2023 | Investing Daily (Ad)

This Trade Strategy Outpaces Almost Anything

Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself.

March 9, 2023 | finance.yahoo.com

Nemaura Medical Announces Receipt of Notice from Nasdaq

February 24, 2023 | finanznachrichten.de

Nemaura Medical, Inc: Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update

February 24, 2023 | finance.yahoo.com

Nemaura Medical, Inc. (NMRD) Reports Q3 Loss, Lags Revenue Estimates

February 24, 2023 | finance.yahoo.com

Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update

February 16, 2023 | finance.yahoo.com

Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference

March 22, 2023 | Investing Daily (Ad)

This Trade Strategy Outpaces Almost Anything

January 31, 2023 | finance.yahoo.com

Nemaura Medical Announces Closing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

January 27, 2023 | finance.yahoo.com

Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

January 26, 2023 | marketwatch.com

Nemaura Medical Shares Rise 19% After New Purchase Order

January 26, 2023 | finance.yahoo.com

Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet

January 24, 2023 | finance.yahoo.com

Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants

January 11, 2023 | finance.yahoo.com

Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference

January 7, 2023 | forbes.com

Nemaura Medical

January 4, 2023 | finance.yahoo.com

Nemaura Medical Inc. (NMRD)

December 1, 2022 | finance.yahoo.com

Nemaura Medical to Present at the Planet MIcroCap Showcase: Virtual 2022

November 29, 2022 | finance.yahoo.com

Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom

November 15, 2022 | finance.yahoo.com

Nemaura Medical, Inc. (NMRD) Reports Q2 Loss, Misses Revenue Estimates

November 15, 2022 | finance.yahoo.com

Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update

November 11, 2022 | finance.yahoo.com

Nemaura Medical to Present at the Bernstein 2ND Annual CGM Disruptors Conference

November 4, 2022 | finance.yahoo.com

Nemaura Medical, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

October 12, 2022 | finance.yahoo.com

Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA

October 6, 2022 | marketwatch.com

InvestorNewsBreaks - Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming MicroCap Rodeo Windy City Roundup

October 4, 2022 | finance.yahoo.com

Nemaura Medical to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference

September 30, 2022 | finanznachrichten.de

FinancialBuzz.com: Wearable Medical Devices Revolutionize How Patient Data Can be Tracked

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Company Calendar

Last Earnings: 11/15/2021
Today: 3/22/2023
Fiscal Year End: 3/31/2023
Next Earnings (Estimated): 6/29/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NMRD
CUSIP: N/A
CIK: 1602078
Web: nemauramedical.com
Phone: (646) 416-8000
Fax: N/A
Employees: 25
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $6.50
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $6.00
Forecasted Upside/Downside: +812.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.56)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-13,890,000.00
Net Margins: N/A
Pretax Margin: -3,382.37%
Return on Equity: -2,921.93%
Return on Assets: -75.78%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.83
Quick Ratio: 0.65

Sales & Book Value

Annual Sales: $500,000.00
Price / Sales: 41.15
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.02 per share
Price / Book: 35.60

Miscellaneous

Outstanding Shares: 28,900,000
Free Float: 14,507,000
Market Cap: $20.58 million
Optionable: Optionable
Beta: -0.02

Key Executives

Dewan Fazlul Hoque Chowdhury
Chairman, President, CEO, CFO & CAO

Arash Ghadar
Chief Operating Officer

Richard Toon
Manager-Technical & Business Development

Bashir Timol
Director & Chief Business Officer

Jay L. Warner
Head-US Commercial Operations

Key Competitors

View All Competitors

NMRD Stock - Frequently Asked Questions

Should I buy or sell Nemaura Medical stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nemaura Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NMRD shares.
View NMRD analyst ratings or view top-rated stocks.
What is Nemaura Medical's stock price forecast for 2023?: 2 Wall Street analysts have issued 12-month target prices for Nemaura Medical's stock. Their NMRD share price forecasts range from $6.00 to $7.00. On average, they predict the company's share price to reach $6.50 in the next year. This suggests a possible upside of 812.9% from the stock's current price.
View analysts price targets for NMRD or view top-rated stocks among Wall Street analysts.
How have NMRD shares performed in 2023?: Nemaura Medical's stock was trading at $1.7171 at the beginning of the year. Since then, NMRD shares have decreased by 58.5% and is now trading at $0.7120.
View the best growth stocks for 2023 here.
Are investors shorting Nemaura Medical?: Nemaura Medical saw a decrease in short interest in February. As of February 28th, there was short interest totaling 37,700 shares, a decrease of 71.7% from the February 13th total of 133,300 shares. Based on an average trading volume of 153,300 shares, the short-interest ratio is currently 0.2 days. Approximately 0.3% of the shares of the company are short sold.
View Nemaura Medical's Short Interest.
When is Nemaura Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our NMRD earnings forecast.
How were Nemaura Medical's earnings last quarter?: Nemaura Medical Inc. (NASDAQ:NMRD) released its earnings results on Monday, November, 15th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by $0.04.

What is Nemaura Medical's stock symbol?: Nemaura Medical trades on the NASDAQ under the ticker symbol "NMRD."
Who are Nemaura Medical's major shareholders?: Nemaura Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%).
How do I buy shares of Nemaura Medical?: Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Nemaura Medical's stock price today?: One share of NMRD stock can currently be purchased for approximately $0.71.
How much money does Nemaura Medical make?: Nemaura Medical (NASDAQ:NMRD) has a market capitalization of $20.58 million and generates $500,000.00 in revenue each year. The company earns $-13,890,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.
How can I contact Nemaura Medical?: Nemaura Medical's mailing address is 57 WEST 57TH STREET, MANHATTAN NY, 10019. The official website for the company is nemauramedical.com. The company can be reached via phone at (646) 416-8000 or via email at brets@coreir.com.

This page (NASDAQ:NMRD) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Nemaura Medical - NMRD Stock Forecast, Price & News

Nemaura Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Nemaura Medical (NASDAQ:NMRD) Stock

NMRD Stock News Headlines

NMRD Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

NMRD Stock - Frequently Asked Questions

Overall MarketRank^™